These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14463992)

  • 1. [2-hydroxy-3-(N-2-hydroxyethyl-N-methylamino)-propyl]-1,3-dimethylxanthine nicotinate].
    LENNARTZ H
    Arzneimittelforschung; 1962 Jul; 12():675-9. PubMed ID: 14463992
    [No Abstract]   [Full Text] [Related]  

  • 2. [ON THE TREATMENT OF APOPLEXY WITH COMPLAMIN (7-(2-HYDROXY-3-(N-2-HYDROXYETHYL-N-METHYLAMINO)PROPYL)THEOPHYLLINE NICOTINATE].
    FRUHMANN H
    Med Welt; 1963 Oct; 41():2084-7. PubMed ID: 14134155
    [No Abstract]   [Full Text] [Related]  

  • 3. [2-hydroxy-3-(N-2-hydroxyethyl-N-methylamino)-propyl]-1,3-dimethylxanthine nicotinate].
    STAMM H
    Arzneimittelforschung; 1962 Jul; 12():679-82. PubMed ID: 13916159
    [No Abstract]   [Full Text] [Related]  

  • 4. [2-hydroxy-3-(N-2-hydroxyethyl-N-methylamino)-propyl]-1,3-dim-exthylxanthinenicotinate on cerebrospinal fluid pressure and cerebral circulation].
    HEMMER R; DIEZEMANN E
    Arzneimittelforschung; 1962 Jul; 12():672-5. PubMed ID: 13906366
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of acute cerebrovascular disorders by the nicotinic acid ester of 7-(2-hydroxyethyl)-theophylline (hesotin)].
    BARTOUSEK V; CERNY J; DUBANSKY B
    Ther Umsch; 1960 May; 17():182-5. PubMed ID: 13797315
    [No Abstract]   [Full Text] [Related]  

  • 6. [TREATMENT OF HYPERCHOLESTEREMIA WITH COMPLAMIN (7-/2-HYDROXY-3-(N-2-HYDROXYETHYL-N-METHYLAMINO)-PROPYLTHEOPHYLLINE NICOTINATE)].
    BRANDEL E
    Z Gesamte Inn Med; 1965 May; 20():283-7. PubMed ID: 14306484
    [No Abstract]   [Full Text] [Related]  

  • 7. [THE EFFECT OF 7-(2-HYDROXY-3-(N-2-HYDROXYETHYL-N-METHYLAMINO)-PROPYL-THEOPHYLLINE NICOTINATE AND OTHER PURINE BODIES ON THE RESPIRATION AND ELECTROCARDIOGRAM OF GUINEA PIGS AND RATS IN HISTOTOXIC OXYGEN DEFICIENCY].
    REICHERTZ P
    Arzneimittelforschung; 1963 Dec; 13():1084-92. PubMed ID: 14216047
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the changes in the cerebral blood volume under the influence of 3-(methylhydroxyethylamino)-2-hydroxypropyl-theophylline nicotinate with the aid of cranial rheography].
    SCHREIBER H
    Med Klin; 1960 Mar; 55():509-11. PubMed ID: 14443546
    [No Abstract]   [Full Text] [Related]  

  • 9. [COMPARATIVE ANALYSIS OF THE VASCULAR EFFECTS OF 3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL-THEOPHYLLINE NICOTINATE, NICOTINIC ACID AND THEOPHYLLINE].
    DEGREGORIO G; BUDA A; FIDECARO A
    Riforma Med; 1964 Aug; 78():937-41. PubMed ID: 14222308
    [No Abstract]   [Full Text] [Related]  

  • 10. [methylhydroxyethylamino]-2-hydroxypropyltheophylline nicotinate)].
    GOTTSTEIN U; BERNSMEIER A; STEINER K
    Klin Wochenschr; 1962 Aug; 40():772-8. PubMed ID: 13900788
    [No Abstract]   [Full Text] [Related]  

  • 11. [New administration technic for 7,2-hydroxy-3-(N-hydroxyethyl-N-methylamino)-propyl-1,3-dimethylxanthine, pyridine-3-carboxylate (Complamine). Shock-dose arterioclysis].
    Rossano C; Testasecca D; Giugliano F; Memé E
    Minerva Anestesiol; 1974 Mar; 40(3):124-31. PubMed ID: 4822934
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preparation and in vivo control of the sustained release of a delayed-action preparation: 7-(2-hydroxy-3-((2-hydroxyethyl)-methylamino)-propyl)-thiophylline nicotinate].
    Belligno A; Zanotti A; Girlando M; Ottaviano G
    Boll Chim Farm; 1972 Aug; 111(8):500-6. PubMed ID: 4647090
    [No Abstract]   [Full Text] [Related]  

  • 13. [A new product acting on cerebral circulation: results of the use in neurosurgery of 7-(2 hydroxy-3-N-2-hydroxy-ethyl-N-methylamino propyl) 1-3 dimethylaxanthine pyridine-3-carboxyl or complamin].
    Pouyanne H; Guérin J; Maurin P
    J Med Bord; 1967 Nov; 114(11):1693-702. PubMed ID: 5602594
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the effects of drugs on the cerebral vessels].
    GLONING K; KLAUSBERGER EM
    Wien Klin Wochenschr; 1959 Nov; 71():880-3. PubMed ID: 13828490
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trial of the treatment of peripheral circulation disorders with Complamine].
    SPERLING M
    Munch Med Wochenschr; 1962 Jul; 104():1273-8. PubMed ID: 13915730
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of long-term therapy with Complamin].
    EHRENBERG H
    Hippokrates; 1961 Dec; 32():937-40. PubMed ID: 13889493
    [No Abstract]   [Full Text] [Related]  

  • 17. [ON COMPLAMIN].
    JENSEN BS
    Ugeskr Laeger; 1963 Aug; 125():1167-70. PubMed ID: 14045855
    [No Abstract]   [Full Text] [Related]  

  • 18. [ON THE TREATMENT OF CEREBRAL AND PERIPHERAL CIRCULATORY DISORDERS. (REPORT ON CLINICAL EXPERIENCES WITH COMPLAMIN)].
    LOOS M
    Med Welt; 1964 Aug; 32():1710-2. PubMed ID: 14291150
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the treatment of dermatological disease pictures with Complamin].
    KLEINHANS H
    Med Klin; 1962 Feb; 57():239-40. PubMed ID: 14456820
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the treatment of cerebral sclerosis with complamine].
    KESSENS L
    Med Welt; 1960 Nov; 47():2517-8. PubMed ID: 13752735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.